- Vivus (NASDAQ:VVUS): Q1 GAAP EPS of -$0.49 beats by $0.31.
- Revenue of $19.63M (+21.5% Y/Y) beats by $1.93M.
- Press Release
- More news on: VIVUS, Inc., Earnings news and commentary, Healthcare stocks news, ,
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
CAMPBELL, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that it has completed the solicitation of an in-court prepackaged plan of reorganization, under which IEH Biopharma LLC (“ IEH ...
CAMPBELL, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that it has updated its agreement regarding its corporate debt with Icahn Enterprises Holdings L.P. (dba IEH Biopharma LLC), which holds ...
3 Penny Stocks To Watch This Week When we talk about penny stocks , we aren’t just explaining 2, 3, 4, or 5 simple letters then say, “here you go”. The whole idea behind putting together an actual list of penny stocks is to have a point of reference. If this were blindly ...